Drugs and the CVS: Heart Flashcards

1
Q

what are the channels involved in reaching the threshold for the AP i.e. the pacemaker potential?

A

1) [I]f (funny channel) : mixed current; slow spontaneous depolarisation due to a mix of Na+ and K+
- initial and end of the potential

2) [I]Ca (fast calcium influx) depolarisation:
- Na+ inactivated; produces slow conduction velocity

3) [I]K (potassium) repolarisation:
- K+ is effluxed
- Ca2+ inactivated

NB pacemaker potentials don’t have a true resting potential (it begins from a lower mV to that of myocardial potentials)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the effect of the SNS on cAMP and the channels?

A

increases cAMP

increases [I]f and [I]ca (promote AP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the effect of the PNS on cAMP and the channels?

A

decreases cAMP

increases [I]k

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the actions of PKA activated by cAMP?

A

o Phosphorylates proteins in the myofibril.

o Induces CICR in the SR by stimulating Ca2+ influx into SR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the proportions of calcium provided by depolarisation-induced Ca2+ influx and by CICR?

A

The majority (75-85%) of Ca2+ is from CICR

20-25% comes from DICR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is activated to cause the increase in cAMP during beta 1 stimulation?

A

adenylate cyclase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what mediates the removal of calcium post-contraction?

A

(1) Plasma membrane Ca2+ ATPase (ATPase Ca2+ channel)
(2) Sodium Calcium Exchanger (Na+/Ca2+ exchanger)

mediate removal of Ca2+ from the cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what part of the heart drives heart rate?

A

SAN (start of electrical activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the main ion driving heart APs?

A

calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the role of “funny channels” ?

A

initiate depolarisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what contraction is the primary determinant of myocardial oxygen demand?

A

myocyte contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what needs to be done to meet:

  • increased HR?
  • increased after load/contractility?
  • increased preload?
A

(1) increased contractions
(2) increased force contractions
(3) small increase force of contractions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what factors affect myocardial oxygen supply?

A

(1) coronary blood flow

(2) arterial oxygen content

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what drugs affect heart rate? [3]

A
  • Beta blockers (beta 1)
  • calcium channel antagonists
  • ivabradine (blocker of funny channels to slow depolarisation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the effect of beta blockers on the pacemaker potential channels?

A

decrease [I]f and [I]ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the effect of calcium channel antagonists on pacemaker potential channels?

A

decreases [I]ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the effect of ivabradine on pacemaker potential channels?

A

decreases [I]f therefore prolongs the slow depolarisation phase (4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the overall effect of drugs affecting heart rate on the AP?

A

prolong depolarisation by spacing it so decreases HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what drugs affect contractility?

A
  • beta blockers

- calcium channel antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is the effect of beta blockers on contractility and how is this achieved?

A

decreases contractility by reducing phosphorylation and cross-bridge formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is the effect of calcium antagonists on contractility and how is this achieved?

A

block VG L-type calcium channel of:

  • cardiac (non-dihydropyridine/rate slowing)
  • smooth muscle (dihydropyridine/non-rate)

stops further entry of calcium into the myofibrils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are the two classes of calcium antagonists?

give examples

A

(1) non-dihydropyridines
- ->rate slowing
- phenylalkylamines e.g. Verapamil –> affect SAN
- benzothiazepines e.g. diltiazem

(2) dihydropyridine
- -> non-rate slowing
- e.g. amlodipine

remember that verapamil affects pacemaker nodes therefore must be a rate affecting CCB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

where do rate-slowing and non- rate slowing calcium antagonists have their effects?

A
  • rate slowing: cardiac tissue and VSM

- non-rate slowing: VSM only and therefore more potent on it. These have no effect on the heart itself

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is the effect of such a potent drug class like dihydropyridine?

A

reflex tachycardia due to extensive vasodilation:

its effect being purely on VSM means that profound vasodilation causes a reflex tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what drugs affect myocardial oxygen supply/demand?

A

(1) organic nitrates

(2) potassium channel openers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

how do organic nitrates affect myocardial oxygen supply/demand?
e.g. nitroglycerin

A

1) Increases oxygen supply by increasing coronary blood flow by increasing smooth muscle relaxation
2) increased venous blood return due to vasodilation of veins more than arteries

smooth muscle relaxation:

  • directly supply NO
  • increases cGMP
  • stimulates K+ channel opening
  • therefore relaxation due to hyperpolarisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

how do potassium channel openers affect myocardial oxygen supply/demand?

A

stimulates hyperpolarisation and therefore the ability for coronary arteries to contract is impaired

the other drug affecting myocardial supply and demand are organic nitrates (different mechanism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what is the overall effect of the drugs that impact myocardial oxygen supply/demand?

A

decrease demand:decrease preload (due to venous dilation) decrease after load (due to arterial dilation) and therefore demand for oxygen

increase supply: increase coronary blood flow and therefore increase oxygen supply

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what is angina a mismatch of?

A

myocardial supply and demand of oxygen

causes myocardial ischaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what is the treatment plan for angina normally?

A

aim: to reduce the work of the heart as there’s a mismatch of demand and supply

1) beta-blocker or CCA as background treatment (first line).
2) Nitrate for symptomatic treatment (i.e. exercise)
3) Ivabradine – new more specific treatment.
4) Other – e.g. K-channel openers if intolerant to other drugs

Nicorandil
these are second line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what is the effect of beta blockers on heart failure?

A

worsens it due to reduction in cardiac output and increased vascular resistance when beta 2 receptors are blocked

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what are the main adverse effects of beta blockers?

A
  • bradycardia (beta 1)
  • bronchoconstriction (beta 2)
  • hypoglycaemia (beta 2)
  • cold extermities (Raynaud’s; beta 2)
  • worsening peripheral artery disease (beta 3)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what causes the bradycardia as a side effect of beta blockers?

how is it resolved?

A
  • heart block
  • decreased AV conduction

(binding to beta 1 responsible for increase HR)

resolution: provide Pindolol (ISA)
- mixed alpha and beta blockers e.g. carvedilol, with vasodilator activity

34
Q

what are the less obvious, doubted side effects of beta blockers?

A

fatigue, impotence, depression and CNS effects (e.g. nightmares

35
Q

how do beta blockers cause cold extremities?

A

loss of beta 2 mediated cutaneous vasodilation in the extremities

36
Q

how does the CCB side effect profile compare to that of beta blockers?

A

less dangerous

37
Q

what are the side effect of the rate-slowing CCB Verapamil?

A
  • bradycardia and AV block: due to blockage of cardiac Calcium channels
  • constipation :due to blockage of gut calcium channels
  • hyperprolactinaemia
38
Q

what are the side effects of non-rate slowing CCB (dihydropyridines)?

similar effects seen in potassium channel openers and nitrates…

A

e.g. amlodipine: as a non-rate slowing drug it targets vessels rather than myocardium therefore side effects are due to VASODILATION
1) ankle oedema:
due vasodilation increase capillary pressure
2) headache/flushing
these are both due to vasodilation
3) palpitations (reflex)
as a reflex SNS effect in response to vasodilation
4) reflex tachycardia:
due to vasodilation

39
Q

what are the aims of rhythms disturbance treatment?

A
  • reduce sudden death
  • reduce symptoms
  • prevent stroke
40
Q

what are the 3 type of arrhythmia based on site of origin?

A

(1) supra ventricular
(2) ventricular
(3) complex (supra- and ventricular)

41
Q

what drugs can be used for each of the 3 types of arrhythmias?

A

((1) supra ventricular - amiodarone, verapamil

(2) ventricular- flecainide, lidocaine
(3) complex (supra- and ventricular) - disopyramide

42
Q

what are the 4 classes in the Vaughan Williams classification of drugs?
NBKC

A
Class 1 
– Na+ channel blockade.
Class 2
 – Beta-blockers.
Class 3 
– prolongation of repolarisation mainly by K+ channel blockade
Class 4 
– Ca2+ channel blockade.
43
Q

why is the Vaughan Williams classification clinically insignificant?

A

the drugs overlap in properties and can’t be strictly put into classes

44
Q

Name 4 selective anti-arrhythmics used in Vaughan-Williams classification?

A

(1) adenosine
(2) verapamil (non-dihydropyridine CCB)
(3) amiodarone (K+ channel blocker)
(4) digoxin (digitalis)

45
Q

what is the effect of adenosine at its two main target sites?

1) SA and AV nodes
2) Vascular smooth muscle

Class V

A

1) in SA and AV nodes
- acts on adenosine type 1 receptors
- causing a decrease in cAMP
- therefore decrease in ionotropy and chronotropy

2) it can also target VSM (to a smaller extent)
- binding to adenosine type 2A receptors
- by increasing cAMP inhibits myosin light chain kinase
- cause relaxation

NB caffeine is an adenosine receptor antagonist

46
Q

what is the effect of verapamil?

Class IV

A

impact on pacemaker nodes (needed for their autonomic nature) :

  • reduces ventricular responsiveness to atrial arrhythmias
  • blocks VGCC and thus depresses SA firing and subsequent AV node conduction.
47
Q

what is the effect of amiodarone?

Class I, II, III, IV

A

Most likely prolongs hyperpolarisation which reduces chance of re-entry causing depolarisation.
- in SVT and VT with re-entry; conduction loops back to tissue that shouldn’t be depolarised causing jerky contractions

probably involving multiple ion-channel block.

48
Q

what are the adverse effects of amiodarone?

A

o Accumulation in body.
o Skin rashes (photosensitive).
o Hypo- or hyper-thyroidism.
o Pulmonary fibrosis.

49
Q

what type of drug is digoxin?

A

cardiac glycoside targeting transport systems, namely Na/K ATPase

50
Q

what is the use of digoxin?

A

atrial fibrillation and atrial flutter

-these impair ventricular filling and reduce CO

51
Q

what is mechanism of action digoxin?

A

Inhibits the Na/K ATPase causes build up of calcium indirectly in the cell causing vagal stimulation (PNS) to the heart:

  • Na+/Ca2+ symporter allows enter and exit of Na+ and Ca2+ simultaneously
  • Na/K ATPase aims to move Na+ out in exchange for K+ coming in, so Ca2+ can enter with Na+ from the outside, into the inside
  • Na/K ATPase inhibition prevents Na+ exit but Na+ entry (with Ca2+) is under hindered
  • Na+ builds up in the cell, conc gradient shifts towards the cell so calcium also builds up in the cell

increase inotropy–> vagal stimulation to decrease HR, improving cardiac output and contractility

52
Q

what is the effect of central vagal stimulation caused by digoxin?

A

increased refractory period due to reduced removal of Ca2+ post contraction

reduced rate of conduction via AVN so fewer impulses reach the ventricles

53
Q

what is a harmful effect of administering diuretics with digoxin?

A
  • diuretics cause hypokalaemia (increased removal of potassium in exchange for sodium)
  • this reduced the threshold to cause digoxin toxicity
  • potassium competes with digoxin at the Na/K ATPase
  • so low potassium levels mean more digoxin can bind at the site and its effects can be enhanced
54
Q

what maintains the sodium gradient once calcium has been effluxed with sodium after contraction?

A

Na+/K+ ATPase maintains the sodium gradient by allowing sodium out of the cell in exchange for potassium so it can move back into the cell with Ca2+

55
Q

what is used to approximate preload?

A

the ventricular EDV

dependent on venous tone and circulating blood volume

56
Q

what is used to approximate afterload?

A

MAP

57
Q

what CVS features do drugs of the heart target?

A
  • heart rate
  • contractility
  • myocardial demand for oxygen and its supply
58
Q

what channels involved in pacemaker potential are affected by beta blockers?

A

remember: SAN drives heart rate and makes use of pacemaker potential

beta blockers decrease I[f] and I[Ca]

59
Q

what channels involved in pacemaker potential are affected by calcium antagonists?

A

decreased I[Ca]

60
Q

what channels involved in pacemaker potential are affected by ivabradine?

A

decreased I[f]

61
Q

describe the mechanism of action of beta blockers

A
  • Acts on the β-adrenergic receptors (β1 on the heart, β2 on vascular smooth muscle)
  • Decrease SA and AV nodal activity by ↓ cAMP, ↓ Ca2 currents.
  • Supress abnormal pacemakers by ↓ slope of phase 4
62
Q

what are the clinical uses of beta blockers?

A

supraventricular tachycardias namely:

  • atrial fibrillation (irregular, fast beating of atria)
  • atrial flutter (atria contract faster than ventricles)

these need ventricular rate control:

  • affect the rate
  • affect the contractility
63
Q

what are the main contraindications of beta blockers?

These contraindications are due to the unwanted effects of beta receptor blockage

A

1) beta blockers causes BRONCHOCONSTRICTION due to blockage of beta2 needed for bronchodilation
- asthmatics (bronchoconstriction)
- COPD (bronchoconstriction)

2) beta blockers cause HYPOGLYCAEMIA due to blockage of beta 2 preventing gluconeogeneis and glycogenolysis in the liver
- diabetics (hypoglycaemia)

3) beta blockers cause VASOCONSTRICTION due to blockage of beta 2 preventing vasodilation in skeletal muscles
- Raynaud’s (cold extremities)

NB beta 2 needed for: bronchodilation, vasodilation and increased glucose

64
Q

where do dihydropyridines (non-rate slowing) CCBs act?

A

on vascular smooth muscle

e.g. amlodipine, clevidipine

your “-pines”

65
Q

where do non-dihydropyriidnes (rate slowing) CCBs act?

A

on the heart e.g. verapamil and diltiazem and to some extent on VSM

66
Q

what are the clinical uses of CCBs?

A

1) dihydropyridines (non-rate slowing):
hypertension
angina
Raynauds (cold extremities)

2) non-dihyrdopyridines (rate slowing):
hypertension 
angina
atrial fib 
atrial flutter
67
Q

what is the mechanism of action of ivabradine?

A

N.B. used for reducing heart rate

IVabradine prolongs slow depolarization (phase IV) by selectively inhibiting the funny channels If

68
Q

what are the clinical uses of ivabradine?

A
  • chronic stable angina (those who can’t use beta blockers)

- heart failure, reduced ejection fraction 1

69
Q

what are the adverse effects of ivabradine?

A
  • Luminous phenomena/Visual brightness
  • Hypertension
  • Bradycardia
70
Q

what is the mechanism of action of organic nitrates like nitroglycerin?

A
  • Vasodilate by ↑ NO in vascular smooth muscle
  • ↑ in cGMP and smooth muscle relaxation leading to increased coronary blood flow
  • Dilate veins&raquo_space; arteries. ↓ preload

organic nitrates aim to increase coronary blood flow and decrease preload (therefore increase myocardial o2 supply)

71
Q

how do organic nitrates increase the myocardial oxygen supply and reduce the myocardial oxygen demand?

A
  • increase in supply: vasodilation and smooth muscle relaxation increases coronary blood flow
  • decrease in demand: organic nitrates dilate veins more than arteries. This reduces the preload on the heart. Preload is dependent on the venous system
72
Q

what are the clinical uses of organic nitrates?

A

Angina
Acute Coronary syndrome
Pulmonary Oedema

73
Q

what are the adverse effects of organic nitrates?

A
  • Reflex tachycardia (treat with B-blockers)
  • Hypotension
  • Flushing
  • Headache

due to excessive smooth muscle relaxation and venous vasodilation

74
Q

what is the mechanism of action of potassium channel openers?

A

↑ AP duration
↑ Effective refractory period
↑ QT interval
↑ coronary blood flow

75
Q

what are the clinical uses of potassium channel blockers?

A

atrial fib
atrial flutter
ventricular tachycardia

76
Q

what are the adverse effects of potassium channel openers?

A

torsade de pointes

77
Q

name a potassium channel blocker (BLOCKER not opener)?

A

amiodarone

78
Q

simple mechanism of action of digoxin

A

indirect blockage of Ca2+ removal post contraction (i.e increased calcium conc in the cell)

  • Direct inhibition of Na+/K+ ATPase
  • indirect inhibition of Na+/Ca2+ exchanger
  • ↑ [Ca2+]I therefore positive inotropy
  • Stimulates vagus nerve therefore ↓ HR
79
Q

what are the adverse effects of digoxin?

A
  • Cholinergic effects (nausea, vomiting, diarrhea)
  • Blurry yellow vision
  • Arrhythmias
  • AV Block
  • Can lead to hyperkalaemia which indicates a poor prognosis
80
Q

what part of Na/K ATPase does digoxin affect?

what effect does hypokalaemia have on digoxin?

A

K+ receptor competitive antagonist

  • hypokalaemia can enhance digoxin effects
  • Na/K ATPase is inhibited by digoxin so less sodium can leave the cell as no potassium enters
81
Q

why should beta blockers not be given to diabetics?

what alternatives can be given for hypertension?

A

1) bind to β2 receptors are found on the liver:
–> therefore antagonising the receptor prevents hypoglycaemia
(which is the increase in HGO)
2) bind to β1 receptors on the heart
–> decrease palpitations, therefore masking the symptoms of hypoglycaemia (hypoglycaemia causes SNS symptoms like palpitations normally )

alternatives:
ACEi
ARBs